Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

COVID-19 Instant Screening test, page-551

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 551 Last

Share
Profile

Follow
pilko3

6,825 Posts.

868

09/02/22

13:34

Post #: 59457148
Share

Originally posted by SteadyEddie: ↑

Hi again,
to correct what had posted - yes ResApp is aiming to be accepted as a valid screening test - not diagnostic test.
following on from my post I don't realistically see how ResApp Dx will be able to screen for asymptomatic patients - ( no symptoms, no cough , no shortness of breath - my guess accuracy well below 50%. In symptomatic patients with a cough - accuracy maybe 70-80%. In patients with Covid pneumonia - I'd be hoping for 80-90%+. no word from management how much longer we will have to wait for results.

I did hear that the sleepcheck meeting with FDA went very well and that they are confident of approval in coming months.

In the meantime I see revenues building and giving confidence to shareholders ...

Expand

Who did you hear from that the Sleepcheck meeting with the FDA went very well?

RAP Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

VUL

Vulcan appoints investment bank and M&A veteran to board

There are more pages in this discussion • 471 more messages in this thread...

First 551 Last

Add RAP (ASX) to my watchlist

SPONSORED BY